保險保單資訊站

SphI、南山hr、SphI在PTT/mobile01評價與討論,在ptt社群跟網路上大家這樣說

SphI關鍵字相關的推薦文章

SphI在南山人壽好EASY 終身醫療健康保險(樣本)的討論與評價

南山人壽好EASY 終身醫療健康保險_SPHI. 第1 頁,共27 頁. 南山人壽好EASY 終身醫療健康保險(樣本). 住院日額保險金、加護病房暨燒燙傷中心醫療保險金.

SphI在(停售)南山人壽好EASY終身醫療健康保險(SPHI) - Finfo的討論與評價

1~6級失能豁免保險費。疾病等待期:30天。投保年齡:主約被保險人0-65歲。保額限制:500~5000元。本附約保險期間內,被保險人所申領之各項保險金累計總額最高以單位日 ...

SphI在SphI | NEB的討論與評價

SphI has a High Fidelity version SphI-HF ® (NEB #R3182). High Fidelity (HF) Restriction Enzymes have 100% activity in rCutSmart Buffer; single-buffer ...

SphI在ptt上的文章推薦目錄

    SphI在PaeI (SphI) (10 U/µL) - Thermo Fisher Scientific的討論與評價

    Thermo Scientific PaeI (SphI) restriction enzyme recognizes GCATG^C sites and cuts best at 37°C in B buffer (Isoschizomers: BbuI, SphI).

    SphI在SphI-HF ® #R3182 - NEB UK的討論與評價

    SphI -HF #R3182 · Engineered for improved performance · 100% activity in rCutSmart Buffer · Time-Saver™. qualified for digestion in 5-15 minutes · Reduced star ...

    SphI在Cloning, expression and sequence analysis of the SphI ...的討論與評價

    SphI, a type II restriction-modification (R-M) system from the bacterium Streptomyces phaeochromogenes, recognizes the sequence 5'-GCATGC.

    SphI在SphI - Promega Corporation的討論與評價

    SphI · Capable of digesting DNA in 15 minutes or less · Active and capable of digestion directly in GoTaq® Green Master Mix · Blue/white cloning qualified, ...

    SphI在SphI restriction enzyme - Takara Bio的討論與評價

    SphI restriction site: G CATG | C C | GTAC G. Supplied buffer: H. Effect of DNA methylation: enzyme activity is not affected by CG methylase.

    SphI在SphI, Restriction Enzymes - Jena Bioscience的討論與評價

    For in vitro use only! Unit Definition: One unit is the amount of enzyme required to completely digest 1 μg of Lambda DNA (1 site) in 1 hour in a total ...

    SphI在Thermo Scientific™ PaeI (SphI) (10 U/µL)的討論與評價

    Thermo Scientific PaeI (SphI) restriction enzyme recognizes GCATG^C sites and cuts best at 37°C in B buffer (Isoschizomers: BbuI, SphI). Thermo Scientific.

    SphI的PTT 評價、討論一次看



    更多推薦結果